| 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis JA Singh, KG Saag, SL Bridges Jr, EA Akl, RR Bannuru, MC Sullivan, ... Arthritis & rheumatology 68 (1), 1-26, 2016 | 3894 | 2016 |
| 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid … JA Singh, DE Furst, A Bharat, JR Curtis, AF Kavanaugh, JM Kremer, ... Arthritis care & research 64 (5), 625-639, 2012 | 2265 | 2012 |
| The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine NC Wright, AC Looker, KG Saag, JR Curtis, ES Delzell, S Randall, ... Journal of bone and mineral research 29 (11), 2520-2526, 2014 | 2076 | 2014 |
| American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis KG Saag, GG Teng, NM Patkar, J Anuntiyo, C Finney, JR Curtis, ... Arthritis Care & Research: Official Journal of the American College of …, 2008 | 2063 | 2008 |
| Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research E Shane, D Burr, B Abrahamsen, RA Adler, TD Brown, AM Cheung, ... Journal of bone and mineral research 29 (1), 1-23, 2014 | 1922* | 2014 |
| Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research E Shane, D Burr, PR Ebeling, B Abrahamsen, RA Adler, TD Brown, ... Journal of Bone and Mineral Research 25 (11), 2267-2294, 2010 | 1296 | 2010 |
| Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study LA Merlino, J Curtis, TR Mikuls, JR Cerhan, LA Criswell, KG Saag Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 1240 | 2004 |
| American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis JM Grossman, R Gordon, VK Ranganath, C Deal, L Caplan, W Chen, ... Arthritis care & research 62 (11), 1515-1526, 2010 | 990 | 2010 |
| Population‐based assessment of adverse events associated with long‐term glucocorticoid use JR Curtis, AO Westfall, J Allison, JW Bijlsma, A Freeman, V George, ... Arthritis Care & Research 55 (3), 420-426, 2006 | 656 | 2006 |
| American College of Rheumatology guidance for COVID‐19 vaccination in patients with rheumatic and musculoskeletal diseases: version 3 JR Curtis, SR Johnson, DD Anthony, RJ Arasaratnam, LR Baden, ... Arthritis & Rheumatology 73 (10), e60-e75, 2021 | 590 | 2021 |
| Greater trochanteric pain syndrome: epidemiology and associated factors NA Segal, DT Felson, JC Torner, Y Zhu, JR Curtis, J Niu, MC Nevitt, ... Archives of physical medicine and rehabilitation 88 (8), 988-992, 2007 | 508 | 2007 |
| A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early … LW Moreland, JR O'Dell, HE Paulus, JR Curtis, JM Bathon, EW St. Clair, ... Arthritis & Rheumatism 64 (9), 2824-2835, 2012 | 505 | 2012 |
| Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists JR Curtis, N Patkar, A Xie, C Martin, JJ Allison, M Saag, D Shatin, ... Arthritis & Rheumatism 56 (4), 1125-1133, 2007 | 503 | 2007 |
| The epidemiology of glucocorticoid-associated adverse events AK McDonough, JR Curtis, KG Saag Current opinion in rheumatology 20 (2), 131-137, 2008 | 461 | 2008 |
| Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis JD Greenberg, JM Kremer, JR Curtis, MC Hochberg, G Reed, P Tsao, ... Annals of the rheumatic diseases 70 (4), 576-582, 2011 | 446 | 2011 |
| Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases CG Grijalva, L Chen, E Delzell, JW Baddley, T Beukelman, KL Winthrop, ... Jama 306 (21), 2331-2339, 2011 | 416 | 2011 |
| Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials SB Cohen, Y Tanaka, X Mariette, JR Curtis, EB Lee, P Nash, KL Winthrop, ... Annals of the rheumatic diseases 76 (7), 1253-1262, 2017 | 414 | 2017 |
| High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis K Au, G Reed, JR Curtis, JM Kremer, JD Greenberg, V Strand, DE Furst, ... Annals of the rheumatic diseases 70 (5), 785-791, 2011 | 404 | 2011 |
| Use of biologics in rheumatoid arthritis: current and emerging paradigms of care JR Curtis, JA Singh Clinical therapeutics 33 (6), 679-707, 2011 | 399 | 2011 |
| Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity DH Solomon, J Kremer, JR Curtis, MC Hochberg, G Reed, P Tsao, ... Annals of the rheumatic diseases 69 (11), 1920-1925, 2010 | 390 | 2010 |
Ted MikulsStokes Shackleford Professor of Rheumatology, University of Nebraska Medical CenterE-mailová adresa ověřena na: unmc.edu
